CN102603561B - 脱氢枞胺衍生物及其在制备抗肿瘤药物中的应用 - Google Patents
脱氢枞胺衍生物及其在制备抗肿瘤药物中的应用 Download PDFInfo
- Publication number
- CN102603561B CN102603561B CN201210035875.6A CN201210035875A CN102603561B CN 102603561 B CN102603561 B CN 102603561B CN 201210035875 A CN201210035875 A CN 201210035875A CN 102603561 B CN102603561 B CN 102603561B
- Authority
- CN
- China
- Prior art keywords
- dehydroabietylamine
- application
- dehydroabietylamine derivatives
- derivatives
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC(C)c(cc(CCC1C2(C)CCCC1(C)C*)c2c1)c1N=Cc1cc(Br)cc(Br)c1O Chemical compound CC(C)c(cc(CCC1C2(C)CCCC1(C)C*)c2c1)c1N=Cc1cc(Br)cc(Br)c1O 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
脱氢枞胺衍生物,其结构式表示:
Description
本申请为《脱氢枞胺衍生物及其在杀菌抗肿瘤药物中的应用》(申请日:2009年6月18日;申请号:200910033318.9)的分案申请。
一、技术领域
本发明涉及脱氢枞胺衍生物Schiff碱类化合物,及其在制备抗肿瘤药物中的应用。
二、背景技术
从天然植物中提取或人工合成在树脂酸C环及B环上的不同位置含有不同取代基的新结构化合物,研究它们的生物活性可以发现,许多产物具有一些不同于母体化合物的抗菌、抗癌、抗艾滋病及其它抗病毒的生物活性,目前这方面已经成为一个研究热点。从Sequoiasempervirens中分离得到了C环上含有羟基、B环上含有羰基的脱氢枞烷骨架的产物,这些产物对肺癌及乳腺癌有很好的抗癌活性;C环上含有邻二酚的脱氢枞酸衍生物,是非常有效的生物体自由基清除剂,具有开发新药的价值;C环上11及12位上有两个羟基的脱氢枞酸衍生物,发现对真菌及癌细胞有很好的活性。脱氢枞胺是松香胺的典型成分,具有光学活性,是一种重要的林产品,在造纸、医药、农药、化工等方面有着广泛的应用。由于它是松香酸的衍生物,因而脱氢枞胺及其醋酸盐具有一定的生物活性,可以作为优异的杀虫剂、杀菌剂和防霉防藻剂;另外,由于脱氢枞胺中存在天然手性碳,因而它可以作为优良的光学拆分剂。脱氢枞胺还被用作金属缓蚀剂、原油破乳剂、润滑油添加剂、表面活性剂等。
三、发明内容
技术问题:本发明提供一类脱氢枞胺衍生物Schiff碱类化合物,及其在制备抗肿瘤药物中的应用。
技术方案:脱氢枞胺衍生物,其特征在于其结构式表示:
上述的脱氢枞胺衍生物在制备抗肿瘤药物中的应用。
有益效果:脱氢枞胺衍生物Schiff碱类化合物对白血病细胞(U-937和HL-60)、卵巢癌细胞(Hey-1B)、***癌细胞(Pc-3和Du-145)及小白鼠皮肤黑色素细胞瘤(B16)有非常好的毒杀作用。
四、具体实施方式
以下的具体实施例是对本发明的进一步说明,而不意味着本发明的内容仅限于所举实例的范围。
实施例1
3,5-二溴水杨醛缩12-氨基乙酰脱氢枞胺Schiff碱式(9)化合物
N2保护下,在配有电动搅拌、滴液漏斗、回流冷凝管和温度计的250mL四口瓶中,加入3.42g(10mmol)12-氨基乙酰脱氢枞胺溶于20mL无水乙醇的溶液,加热至回流后,滴加3.02g(12.2mmol)3,5-二溴水杨醛的20mL无水乙醇溶液。反应3h后,冷却抽滤、烘干得到标题化合物4.79g,得率85.9%。以无水乙醇重结晶得红褐色晶体。熔点:231~232℃。
FT-IR(KBr压片)v/cm-1:3432.24,3256.56,3081.33,2957.03,2929.89,2864.90,1643.55,1617.19,1565.01,1497.81,1441.52,1375.37,1289.23,1157.06,1093.74,972.44,860.64,775.83,687.60;1HNMR(400MHZ,CDCl3)δ:0.99(s,3H),1.24~1.29(m,9H),1.43~1.50(m,3H),1.65(s,3H),1.92~2.09(m,5H),2.33~2.36(d,J=12Hz,1H),2.84~3.14(m,3H),3.29~3.39(m,2H),5.46(s,1H),6.95(s,1H),7.06(s,1H),7.55~7.56(d,J=4Hz,1H),7.77~7.78(d,J=4Hz,1H),8.47(s,1H);EI-MS m/z:603.2(M+1+),540.6,512.6,330.5,302.4,274.4,208.2,185.1;Anal.calcd for C29H36Br2N2O2:C57.63,H 6.00,N 4.63;found:C 57.93,H 6.43,N 4.66
实施例2
对式9所述的新型脱氢枞胺衍生物Schiff碱做了体外抗癌活性测定,卵巢癌细胞(Hey-1B)作为被筛选的癌细胞。具体的实验方法如下:
卵巢癌细胞株Hey-1B,在DMEM动物细胞培养基里培养,培养基中添加了10%的加强型牛血清蛋白和抗生素,通入潮湿空气,控制温度在的37℃,CO2含量5%。非放射性细胞增殖检测以比色法(MTT)确定Hey-1B的细胞活性。
测定方法参照制造商(Promega,Madison,WI)的操作说明,简要步骤如下:在96孔板的每个孔里种入1×104个细胞,培养一天后用样品处理,处理浓度梯度分别为2.5,5,10,20,40,80μg/mL,培养48小时。培养结束后,在每个孔中加入50μL Cell Titer 96Aqueous试剂(用1×PBS稀释至40%,v/v),37℃继续培养2小时,最后使用96孔板读板器在490nm处检测吸光率OD490(全波长扫描式微盘分析仪Spectra Max 340)。所得各孔平均OD值依照对照样借助统计学检验计算其肿瘤细胞抑制率。
实验结果:样品溶解在DMEM动物细胞培养基里,生长的癌细胞明显被抑制,Hey-1B细胞凋亡。
Claims (2)
1.脱氢枞胺衍生物,其特征在于其结构式表示:
2.权利要求1所述的脱氢枞胺衍生物在制备抗肿瘤药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210035875.6A CN102603561B (zh) | 2009-06-18 | 2009-06-18 | 脱氢枞胺衍生物及其在制备抗肿瘤药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210035875.6A CN102603561B (zh) | 2009-06-18 | 2009-06-18 | 脱氢枞胺衍生物及其在制备抗肿瘤药物中的应用 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910033318A Division CN101580477B (zh) | 2009-06-18 | 2009-06-18 | 脱氢枞胺衍生物及其在杀菌抗肿瘤药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102603561A CN102603561A (zh) | 2012-07-25 |
CN102603561B true CN102603561B (zh) | 2014-03-26 |
Family
ID=46521411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210035875.6A Expired - Fee Related CN102603561B (zh) | 2009-06-18 | 2009-06-18 | 脱氢枞胺衍生物及其在制备抗肿瘤药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102603561B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103113368A (zh) * | 2013-02-04 | 2013-05-22 | 南京林业大学 | 六氢菲并四氢吲嗪类化合物及其制备方法和应用 |
CN104961673A (zh) * | 2015-06-26 | 2015-10-07 | 南京林业大学 | 一种联吡啶脱氢枞胺希夫碱化合物及其制备方法 |
CN106220570B (zh) * | 2016-07-26 | 2019-07-30 | 南京林业大学 | 咪唑脱氢枞胺酰胺类化合物及其制备方法和应用 |
CN106316939B (zh) * | 2016-07-26 | 2019-07-30 | 南京林业大学 | N-2-吡啶酰基-脱氢枞胺及其制备方法和应用 |
CN106220559B (zh) * | 2016-07-26 | 2019-07-30 | 南京林业大学 | N-3-吡啶酰基-脱氢枞胺衍生物及其制备方法和应用 |
CN106220558B (zh) * | 2016-07-26 | 2019-10-18 | 南京林业大学 | N-4-吡啶酰基-脱氢枞胺衍生物及其制备方法和应用 |
CN108299330B (zh) * | 2018-02-06 | 2021-02-12 | 桂林医学院 | 去氢枞酸噁唑烷酮衍生物及其制备方法和应用 |
CN109251154B (zh) * | 2018-10-25 | 2021-01-05 | 广西民族大学 | 一种脱氢枞酸磺酰脲类化合物及其制备方法与应用 |
CN115819268A (zh) * | 2022-08-22 | 2023-03-21 | 浙江工业大学 | 一类c-14酰胺取代的脱氢松香酸衍生物及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1669347A1 (en) * | 2004-12-10 | 2006-06-14 | Helm AG | Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid |
CN101003548A (zh) * | 2006-12-12 | 2007-07-25 | 中国林业科学研究院林产化学工业研究所 | 松香基二萜改性α-氨基磷酸酯、制备方法及抗肿瘤应用 |
CN101219949A (zh) * | 2007-11-30 | 2008-07-16 | 中国林业科学研究院林产化学工业研究所 | 一种枞酸的制备方法 |
-
2009
- 2009-06-18 CN CN201210035875.6A patent/CN102603561B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1669347A1 (en) * | 2004-12-10 | 2006-06-14 | Helm AG | Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid |
CN101003548A (zh) * | 2006-12-12 | 2007-07-25 | 中国林业科学研究院林产化学工业研究所 | 松香基二萜改性α-氨基磷酸酯、制备方法及抗肿瘤应用 |
CN101219949A (zh) * | 2007-11-30 | 2008-07-16 | 中国林业科学研究院林产化学工业研究所 | 一种枞酸的制备方法 |
Non-Patent Citations (6)
Title |
---|
A.G.Tolstikov等.The povarov reaction of cyclopentadiene with imines from methyl 12-amino-dehydroabietate.《Heteroatom Chemistry》.2005,第16卷(第7期),605-612. |
Synthesis and biological activity of Schiff bases derived from dehydroabietylamine and benzaldehyde derivatives;Xiaoping Zhao等;《Organic synthesis》;20071231;第80卷(第8期);1373-1375 * |
The povarov reaction of cyclopentadiene with imines from methyl 12-amino-dehydroabietate;A.G.Tolstikov等;《Heteroatom Chemistry》;20051231;第16卷(第7期);605-612 * |
Xiaoping Zhao等.Synthesis and biological activity of Schiff bases derived from dehydroabietylamine and benzaldehyde derivatives.《Organic synthesis》.2007,第80卷(第8期),1373-1375. |
含氟脱氢枞胺Schiff碱的合成及抑菌活性;饶小平等;《林产化学与工业》;20070430;第27卷(第2期);97-99 * |
饶小平等.含氟脱氢枞胺Schiff碱的合成及抑菌活性.《林产化学与工业》.2007,第27卷(第2期),97-99. |
Also Published As
Publication number | Publication date |
---|---|
CN102603561A (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102603561B (zh) | 脱氢枞胺衍生物及其在制备抗肿瘤药物中的应用 | |
CN101580477B (zh) | 脱氢枞胺衍生物及其在杀菌抗肿瘤药物中的应用 | |
Xu et al. | Synthesis and antitumor activity of novel 2-substituted indoline imidazolium salt derivatives | |
CN105712932B (zh) | 一种含1-甲基-3-芳基-4-氯吡唑结构的吡唑肟醚化合物的制备和应用 | |
US9211333B2 (en) | Anti-cancer agents synthesized based on miliusane compounds | |
Li et al. | Design, synthesis, and anticancer evaluation of novel indole derivatives of ursolic acid as potential topoisomerase II inhibitors | |
CN101967135B (zh) | 一种4-芳基香豆素类化合物的制备方法 | |
Sisto et al. | Synthesis and biological evaluation of carvacrol-based derivatives as dual inhibitors of H. pylori strains and AGS cell proliferation | |
CN103058960A (zh) | 卡巴他赛多晶型形式及其制备方法 | |
Cao et al. | Synthesis, characterization, and biological evaluations of 1, 3, 5-triazine derivatives of metformin cyclization with berberine and magnolol in the presence of sodium methylate | |
Meza-Morales et al. | A new family of homoleptic copper complexes of curcuminoids: Synthesis, characterization and biological properties | |
Kowalski et al. | Ferrocenyl derivatives of pterocarpene and coumestan: Synthesis, structure and anticancer activity studies | |
Oniciuc et al. | Benzoquinoline derivatives: an attractive approach to newly small molecules with anticancer activity | |
CN108299398B (zh) | 一种具有抗肿瘤活性含咔唑的喹唑啉衍生物及其制药用途 | |
Pathan et al. | An efficient one pot I2/DMSO mediated synthesis and molecular modeling of novel fused pyrimidine‐chromone hybrids bearing potential antibacterial and antifungal pharmacophores sites | |
Li et al. | Synthesis and biological evaluation of strictosamide derivatives with improved antiviral and antiproliferative activities | |
Karcev et al. | Selective and reversible 1, 3-dipolar cycloaddition of 2-(2-oxoindoline-3-ylidene) acetates with nitrones in the synthesis of functionalized spiroisoxazolidines | |
US9822071B2 (en) | Anticancer miliusane lactams | |
Sondhi et al. | Synthesis, anti‐inflammatory, and anticancer activity evaluation of some heterocyclic amidine and bis‐amidine derivatives | |
CN103396437B (zh) | 双(三环己基锡)二元羧酸酯及制备方法与应用 | |
CN107698648B (zh) | 含胆甾醇的萘酰亚胺类衍生物及其合成和应用 | |
Calvo-Martín et al. | New Experimental Conditions for Diels–Alder and Friedel-Crafts Alquilation Reactions with Thiophene: A New Selenocyanate with Potent Activity against Cancer | |
CN103360423A (zh) | 一苄基锡芳香醛缩芳胺Schiff 碱配合物及制备方法与应用 | |
Aiello et al. | Synthesis and Antioxidative Properties of 1, 2, 3, 4-Tetrahydropyridine Derivatives with Different Substituents in 4-Position | |
CN111039844A (zh) | 多取代芳基吡咯化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 Termination date: 20150618 |
|
EXPY | Termination of patent right or utility model |